We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$132M
AUM Growth
-$14.8M
Cap. Flow
-$22.6M
Cap. Flow %
-17.18%
Top 10 Hldgs %
54.12%
Holding
159
New
33
Increased
15
Reduced
30
Closed
40

Top Buys

Rank Stock Value
1
LBRDK icon
Liberty Broadband Class C
LBRDK
+$3.61M
2
SI
Silvergate Capital Corporation
SI
+$3.17M
3
ACIA
Acacia Communications Inc
ACIA
+$2.94M
4
TSG
The Stars Group Inc.
TSG
+$2.01M
5
BABA icon
Alibaba
BABA
+$1.5M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$4.52M
2
FOX icon
Fox Class B
FOX
+$3.9M
3
RP
RealPage, Inc.
RP
+$3.8M
4
CELG
Celgene Corp
CELG
+$3.65M
5
AGN
Allergan plc
AGN
+$3.33M

Sector Composition

Rank Sector Weight
1 Technology 40.19%
2 Consumer Discretionary 14.17%
3 Healthcare 14.13%
4 Communication Services 6.47%
5 Financials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMC
76
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$119K 0.09%
1,150
-220
-16% -$22.3K
CTMX icon
77
CytomX Therapeutics
CTMX
$741M
$116K 0.09%
+13,900
New +$93.8K
BBD icon
78
Banco Bradesco
BBD
$36.5B
$107K 0.08%
15,839
-5,191
-25% -$32.5K
SPWH icon
79
Sportsman's Warehouse
SPWH
$47.2M
$106K 0.08%
13,200
– –
RLGT icon
80
Radiant Logistics
RLGT
$392M
$98K 0.07%
+17,600
New +$95.2K
HROW icon
81
Harrow
HROW
$1.49B
$93K 0.07%
+12,000
New +$69.5K
JNCE
82
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$93K 0.07%
10,700
-7,600
-42% -$41.1K
AFMD
83
DELISTED
Affimed
AFMD
$92K 0.07%
3,370
+1,200
+55% +$32.1K
CVGI icon
84
Commercial Vehicle Group
CVGI
$142M
$91K 0.07%
14,300
– –
DHX icon
85
DHI Group
DHX
$165M
$88K 0.07%
29,200
+8,900
+44% +$30.2K
AKBA icon
86
Akebia Therapeutics
AKBA
$234M
$87K 0.07%
13,700
-1,100
-7% -$5.23K
TLPH icon
87
Talphera
TLPH
$73.7M
$87K 0.07%
2,070
+935
+82% +$38.2K
MEET
88
DELISTED
The Meet Group, Inc. Common Stock
MEET
$87K 0.07%
17,300
– –
GALT icon
89
Galectin Therapeutics
GALT
$319M
$86K 0.07%
30,200
+12,000
+66% +$41.7K
TDAY
90
USA Today Co
TDAY
$1.05B
$83K 0.06%
+13,000
New +$95.3K
LAB icon
91
Standard BioTools
LAB
$305M
$83K 0.06%
+23,800
New +$83.7K
STR
92
DELISTED
Sitio Royalties
STR
$82K 0.06%
2,900
– –
VKTX icon
93
Viking Therapeutics
VKTX
$4B
$81K 0.06%
+10,100
New +$73.6K
OSG
94
DELISTED
Overseas Shipholding Group Inc.
OSG
$81K 0.06%
35,000
– –
DAKT icon
95
Daktronics
DAKT
$1.05B
$79K 0.06%
+12,900
New +$86.2K
MNOV icon
96
MediciNova
MNOV
$65.5M
$79K 0.06%
+11,700
New +$88K
RBBN icon
97
Ribbon Communications
RBBN
$372M
$79K 0.06%
25,600
+12,200
+91% +$48.6K
CDMO
98
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$79K 0.06%
10,300
– –
PDLI
99
DELISTED
PDL BioPharma, Inc.
PDLI
$78K 0.06%
23,900
+1,000
+4% +$2.9K
ATEN icon
100
A10 Networks
ATEN
$2.06B
$74K 0.06%
10,700
– –
2 3
4
5 6

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

HighVista Strategies's Q4 2019 Portfolio in Review

As of Q4 2019, HighVista Strategies held 159 positions worth $132M, down 10% from $147M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

HighVista Strategies withdrew a net $22.6M in Q4 2019, closing 40 positions and reducing 30 holdings. Its most notable exit was Medicines Co, an estimated $4.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, HighVista Strategies opened a new position in Liberty Broadband Class C worth $3.9M.

  • HighVista Strategies's largest Q4 2019 buy was Liberty Broadband Class C: 31,000 shares worth $3.9M.
  • HighVista Strategies added most to Alibaba in Q4 2019, an estimated $1.5M increase.
  • HighVista Strategies's biggest Q4 2019 reduction was Allergan plc, cutting an estimated $3.33M.
  • HighVista Strategies fully exited Medicines Co in Q4 2019, selling an estimated $4.52M.
  • HighVista Strategies's ten largest holdings make up 54% of its $132M portfolio in Q4 2019.
  • HighVista Strategies opened 33 new positions and closed 40 in Q4 2019.
  • HighVista Strategies's portfolio value fell 10% quarter-over-quarter to $132M.

Based on HighVista Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.